SMTL ID : 1ld7.1

Co-crystal structure of Human Farnesyltransferase with farnesyldiphosphate and inhibitor compound 66

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.00 Å
Oligo State
hetero-oligomer
Ligands
1 x SUC: SUGAR (SUCROSE)(Non-covalent)
1 x ZN: ZINC ION(Non-covalent)
1 x FPP: FARNESYL DIPHOSPHATE(Non-covalent)
1 x U66: (20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE(Non-covalent)
Links
RCSB   PDBe   PDBj   PDBsum   CATH   PLIP
Citation
Bell, I.M. et al., 3-Aminopyrrolidinone farnesyltransferase inhibitors: design of macrocyclic compounds with improved pharmacokinetics and excellent cell potency. J.Med.Chem. (2002)
Release Date
2002-06-19
Peptides
protein farnesyltransferase alpha subunit: A
protein farnesyltransferase beta subunit: B
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

protein farnesyltransferase alpha subunit

protein farnesyltransferase beta subunit

Related Entries With Identical Sequence

1jcq.1 | 1ld8.1 | 1mzc.1 | 1s63.1 | 1sa4.1 | 1tn6.1 | 2f0y.1 | 2h6f.1 | 2h6g.1 | 2h6h.1 | 2h6i.1 | 2iej.1 | 3e37.1 | 3e37.3